Home > Healthcare > Medical Devices > Diagnostic Devices > At-home Drug of Abuse (DOA) Testing Market

At-home Drug of Abuse (DOA) Testing Market Share

Report ID: GMI6485
Published Date: Aug 2023
Report Format: PDF

Download Free Sample

At-home Drug of Abuse Testing Market Share

Some of the eminent market participants operating in the at-home drug of abuse testing market include :

Abbott Laboratories
Dragerwerk AG & Co.KGaA
Assure Tech. (Hangzhou) Co. LTD
Atlas Medical GmbH
Confirm BioSciences
F. Hoffmann-La Roche AG
Siemens Healthineers AG
Thermo Fisher Scientific Inc.
Bio-Rad Laboratories, Inc.
bioMérieux SA
Psychemedics Corporation
OraSure Technologies

These participants are undertaking several growth strategies including partnerships, collaborations, acquisitions & mergers, and new product development & launches to strengthen their product portfolio as well as gain a competitive edge over others.

Authors: Mariam Faizullabhoy , Pratiksha Kamthe

Frequently Asked Questions (FAQ) :

The global market for at-home drug of abuse testing was reached USD 3.5 billion in 2022 and is estimated to account for USD 7.2 billion by 2032, as it allows individuals to conduct drug tests in the privacy of their own homes.

The test strips segment garnered USD 1.7 billion in the year 2022, as it offers quick and straightforward drug testing procedures, providing convenience to individuals.

U.S. at-home drug of abuse testing market exceeded USD 1.2 billion in 2022 and is predicted to witness substantial growth through 2032, owing to high prevalence of drug abuse and substance use disorders in the country.

Confirm BioSciences, F. Hoffmann-La Roche AG, Siemens Healthineers AG, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., bioM